Abstract | OBJECTIVE: METHODS AND RESULTS:
Aliskiren (10 mg/kg/d) or PBS was administered to C57BL/6 mice (6-7 weeks of age; Oriental Yeast, Tokyo, Japan) for 2 weeks via an osmotic pump. Blood pressure was not significantly changed in the 2 groups throughout the experimental period. A perivascular cuff injury was then introduced to the femoral artery and real-time intravital microscopic observation was conducted 24 hours after injury. The number of adherent leukocytes was elevated in the injured mice without aliskiren (43.8+/-9.3/10(-2) mm(2)), whereas that was significantly reduced in the mice with aliskiren (18.4+/-4.4, P<0.05). Treatment of human umbilical vein endothelial cells (HUVECs) with aliskiren significantly reduced the adhesion of THP-1 cells to TNF-alpha-activated HUVECs (P<0.05). Interestingly, TNF-alpha-induced renin activity and angiotensin II production in HUVECs were also blunted by aliskiren. Furthermore, exogenous renin and angiotensin II abrogated the aliskiren-mediated reduction of THP-1 cell adhesion to HUVECs. CONCLUSIONS: Our in vivo and in vitro findings indicate a pivotal role for renin inhibition in vascular inflammation independent of blood pressure.
|
Authors | Jun Ino, Chiari Kojima, Mizuko Osaka, Kosaku Nitta, Masayuki Yoshida |
Journal | Arteriosclerosis, thrombosis, and vascular biology
(Arterioscler Thromb Vasc Biol)
Vol. 29
Issue 11
Pg. 1858-63
(Nov 2009)
ISSN: 1524-4636 [Electronic] United States |
PMID | 19778947
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Amides
- Fumarates
- Reactive Oxygen Species
- Tumor Necrosis Factor-alpha
- aliskiren
- Renin
|
Topics |
- Amides
(pharmacology)
- Animals
- Blotting, Western
- Cells, Cultured
- Disease Models, Animal
- Endothelial Cells
(cytology, drug effects)
- Femoral Artery
(drug effects, injuries)
- Fumarates
(pharmacology)
- Humans
- In Vitro Techniques
- Mice
- Mice, Inbred C57BL
- Oxidative Stress
(physiology)
- Random Allocation
- Reactive Oxygen Species
(metabolism)
- Renin
(antagonists & inhibitors)
- Renin-Angiotensin System
(drug effects, physiology)
- Reverse Transcriptase Polymerase Chain Reaction
- Sensitivity and Specificity
- Tumor Necrosis Factor-alpha
(pharmacology)
|